BPC 5mg + TB 5mg
Preclinical — Animal / cell-model data onlyWhat it is
A blend of BPC-157 and TB-500, two recovery-research peptides combined in one vial. Evidence for each component is largely preclinical.
A single-vial blend of BPC-157 and TB-500 — the two most commonly paired recovery-research peptides. Evidence for each is largely preclinical.
Research context
Studied in relation to:
- Combined tissue-repair research (animal)
Points in its favour in the literature:
- Combines two commonly-paired recovery peptides
Caveats and unknowns:
- Preclinical evidence base
- Both components unlicensed for human use
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Follows the two components; see the BPC-157 and TB-500 profiles for their individual reported ranges.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg total (5 mg + 5 mg) + 2 mL → 5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 10mg | BB10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.